Distinguished in Lupus Nephritis

Philippe Remy

Neurologie, CHU Henri Mondor, Equipe 01-NPI, Université Paris Est Créteil, 
Creteil, FR 
Distinguished in Lupus Nephritis
Neurologie, CHU Henri Mondor, Equipe 01-NPI, Université Paris Est Créteil, 
Creteil, FR 
OverviewLocationsClinical Research

Overview

Philippe Remy practices in Creteil, France. Mr. Remy is rated as a Distinguished expert by MediFind in the treatment of Lupus Nephritis. His top areas of expertise are Lupus Nephritis, Parkinson's Disease, Movement Disorders, Glomerulonephritis, and Kidney Transplant.

His clinical research consists of co-authoring 78 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 11 articles in the study of Lupus Nephritis.

Gender
Male

Locations

Neurologie, CHU Henri Mondor, Equipe 01-NPI, Université Paris Est Créteil, Creteil, France
Other Locations
Neurologie, CHU Henri Mondor, Equipe 01-NPI, Université Paris Est Créteil, Créteil, Et Ecole Normale Supérieure, Paris, France
Marseille, France
Fontenay-sous-bois, 92265, France
France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Study of Pimavanserin Efficacy for the Treatment of Impulse Control Disorders in Parkinson's Disease
Study of Pimavanserin Efficacy for the Treatment of Impulse Control Disorders in Parkinson's Disease
Enrollment Status: Completed
Publish Date: January 01, 2025
Intervention Type: Drug, Procedure, Behavioral
Study Drug: Pimavanserin
Study Phase: Phase 2
A Dose-Ranging Study of the Efficacy, Safety, and Pharmacokinetics of Deferiprone Delayed Release Tablets in Patients With Parkinson's Disease
A Dose-Ranging Study of the Efficacy, Safety, and Pharmacokinetics of Deferiprone Delayed Release Tablets in Patients With Parkinson's Disease
Enrollment Status: Completed
Publish Date: April 10, 2024
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

78 Total Publications

Validation of the French Translation of the Movement Disorder Society Non-Motor Symptoms Scale (MDS-NMS) in Parkinson's Disease.
Validation of the French Translation of the Movement Disorder Society Non-Motor Symptoms Scale (MDS-NMS) in Parkinson's Disease.
Journal: Movement disorders clinical practice
Published: June 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Remy's expertise for a condition
ConditionClose
    View All 24 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile